As of 2024-12-12, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is
-3.76 USD. This ALDX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 5.37 USD, the upside of Aldeyra Therapeutics Inc is
-170.04%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-3.76 USD
Intrinsic Value
ALDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-3.76 - -3.76 |
-3.76 |
-170.04% |
| P/E |
(13.39) - (13.77) |
(11.26) |
-309.8% |
| DDM - Stable |
(5.69) - (19.56) |
(12.63) |
-335.1% |
| DDM - Multi |
(4.49) - (12.28) |
(6.60) |
-223.0% |
ALDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
319.78 |
| Beta |
0.69 |
| Outstanding shares (mil) |
59.55 |
| Enterprise Value (mil) |
266.94 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.36% |
| Cost of Debt |
5.00% |
| WACC |
10.05% |